Sebastian Ewen

Showing 1-11 of 11 articles

Coronary interventions

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial

Scheller B, Ohlow M, Ewen S, Kische S, Rudolph T, Clever Y, Wagner A, Richter S, El-Garhy M, Böhm M, Degenhardt R, Mahfoud F, Lauer B

April 17, 2020 | 10.4244/EIJ-D-19-00723

Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications

Ewen S, Lauder L, Azizi M, Kandzari D, Pathak A, Sharif F, Wijns W, Mahfoud F, Lüscher T

August 3, 2018 | 10.4244/EIJY18M07_1

Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications

Lauder L, Ewen S, Azizi M, Mauri L, Lurz P, Lobo M, Sharif F, Wijns W, Tsioufis C, Mahfoud F

August 3, 2018 | 10.4244/EIJY18M07_2

Other

Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension

Lauder L, Ewen S, Tzafriri A, Edelman E, Lüscher T, Blankestijn P, Dörr O, Schlaich M, Sharif F, Voskuil M, Zeller T, Ukena C, Scheller B, Böhm M, Mahfoud F

May 20, 2018 | 10.4244/EIJ-D-18-00112

Interventions for hypertension

Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control

Ewen S, Lobo M, Pathak A, Schmieder R, Tsioufis C, Wijns W, Mahfoud F

August 20, 2016 | 10.4244/EIJV12I6A132

Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity

Pathak A, Coleman L, Roth A, Stanley J, Bailey L, Markham P, Ewen S, Morel C, Despas F, Honton B, Senard J, Fajadet J, Mahfoud F

August 20, 2015 | 10.4244/EIJV11I4A96

From SYMPLICITY HTN-3 to the Renal Denervation Global Registry: where do we stand and where should we go?

Pathak A, Ewen S, Fajadet J, Honton B, Mahfoud F, Marco J, Schlaich M, Schmieder R, Tsioufis C, Ukena C, Zeller T

May 20, 2014 | 10.4244/EIJV10I1A4

Response and non-response to renal denervation: who is the ideal candidate?

Ukena C, Cremers B, Ewen S, Böhm M, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA10

Expanding the indication spectrum: renal denervation in diabetes

Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka P, Cremers B, Böhm M

May 21, 2013 | 10.4244/EIJV9SRA20

Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure

Böhm M, Ewen S, Linz D, Reil J-C, Schirmer S, Ukena C, Mahfoud F

May 21, 2013 | 10.4244/EIJV9SRA21

First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B

Ewen S, Mahfoud F, Böhm M

January 18, 2013 | 10.4244/EIJV8I9A170

Latest news

NEW ISSUE

200 Issues at the Heart of Interventional Cardiology

January 28, 2022

AHEAD OF PRINT

Simulation-based planning of transcatheter left atrial appendage occlusion

FREE ARTICLE - Nils Perrin et al

January 26, 2022

AHEAD OF PRINT

Features of atherosclerosis in patients with angina and no obstructive coronary artery disease

FREE ARTICLE - Dario Pellegrini et al

January 27, 2022

AHEAD OF PRINT

Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study

FREE ARTICLE - Thomas J. Stocker et al

January 24, 2022

GUIDELINES

2021 ESC/EACTS Guidelines for the management of valvular heart disease

FREE ARTICLE - Alec Vahanian et al.

December 22, 2021

AHEAD OF PRINT

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

AHEAD OF PRINT

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.